Rare genetic variability in human drug target genes modulates drug response and can guide precision medicine

Abstract excerpt

variant confers resistance to tacrine and rivastigmine, which can be overcome by the use of derivatives based on squaric acid scaffolds or tryptophan conjugation. These findings underscore the importance of genetic drug target variability and demonstrate that integration of genomic data and structural information can inform personalized drug selection and genetically guided drug development to overcome resistance.

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Computational Drug Discovery Methods
• Share to Microbial Natural Products and Biosynthesis
• Share to Pharmacogenetics and Drug Metabolism